Federal Court of Australia
FEDERAL COURT OF AUSTRALIA
Novartis Pharmaceuticals Australia Pty Ltd v Bayer Australia Limited (No 2) [2013] FCA 1201 Citation: Novartis Pharmaceuticals Australia Pty Ltd v Bayer Australia Limited (No 2) [2013] FCA 1201
Parties: NOVARTIS PHARMACEUTICALS AUSTRALIA PTY LTD (ACN 004 244 160) v BAYER AUSTRALIA LIMITED (ACN 000 138 714)
File number: NSD 314 of 2013
Judge: ROBERTSON J
Date of judgment: 18 November 2013
Catchwords: EVIDENCE - legal professional privilege - whether implied waiver EVIDENCE - whether paragraph of affidavit admissible -whether probative value of evidence substantially outweighed by danger that it might be unfairly prejudicial to a party
Legislation: Evidence Act 1995 (Cth) s 135
Cases cited: Archer Capital 4A Pty Ltd as trustee for the Archer Capital Trust 4A v Sage Group plc (No 3) [2013] FCA 1160 Australian Agricultural Company Limited v AMP Life Limited [2006] FCA 371 Commissioner of Taxation v Rio Tinto Ltd (2006) 151 FCR 341 DSE (Holdings) Pty Ltd v Intertan Inc (2003) 127 FCR 49 Expense Reduction Analysts Group Pty Ltd v Armstrong Strategic Management and Marketing Pty Limited [2013] HCA 46 Ferella v Official Trustee in Bankruptcy (2010) 188 FCR 68 Fort Dodge Australia Pty Ltd v Nature Vet Pty Ltd [2002] FCA 501
Date of hearing: 13 November 2013
Place: Sydney
Division: GENERAL DIVISION
Category: Catchwords
Number of paragraphs: 31
We try to embed the page this law was scraped from. If the site blocks framing, you still get the link and a local excerpt.
Last checked with source on —
Checking whether the official page can be embedded…
Plain-English simplify of this law: a short summary, key points, and both sides of the argument. Generated on first view via Replicate, then cached. Vote on what helps your study.
No study brief is cached for this law yet. Sign up to generate a plain-English brief.
Sign up to generate